NCT04874753

Brief Summary

COVID-19 pandemic affected the admission of patients to the hospital especially the older patients (\> 65 years old) because of curfews and the reluctance of patients to apply to the hospitals. Chronic kidney disease is characterized with the progressive loss of kidney function over the time and regular follow-up of patients for their kidney function and treatment of complications is recommended in these patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2020

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 2, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2021

Completed
Last Updated

May 6, 2021

Status Verified

May 1, 2021

Enrollment Period

28 days

First QC Date

May 2, 2021

Last Update Submit

May 2, 2021

Conditions

Covid19Chronic Kidney DiseasesProteinuria

Outcome Measures

Primary Outcomes (2)

  • eGFR change

    a rise or decrease in eGFR

    6 months

  • change in proteinuria

    increase or decrease in ptoteinuria levels

    6 months

Secondary Outcomes (1)

  • initiation of renal replacement therapies

    6 months

Interventions

change in kidney function and proteinuriaOTHER

change in eGFR nad proteinuria in patients with chronic kidney disease

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with chronic kidney disease (eGFR\<60 ml/dk) between the ages 18-80 followed up in nephrology outpatient clinic.

You may qualify if:

  • patients with chronic kidney disease on regular follow-up for 6 months before the COVID19 pandemic.

You may not qualify if:

  • patients without chronic kidney disease
  • patients not on routine follow-up for 6 months before the COVID19 pandemic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usak University

Uşak, 64100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19Renal Insufficiency, ChronicProteinuria

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsUrination DisordersUrological ManifestationsSigns and Symptoms

Study Officials

  • Zelal Adıbelli

    Uşak University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Prof. Zelal Adibelli

Study Record Dates

First Submitted

May 2, 2021

First Posted

May 6, 2021

Study Start

November 3, 2020

Primary Completion

December 1, 2020

Study Completion

January 1, 2021

Last Updated

May 6, 2021

Record last verified: 2021-05

Locations

TU(1)